Subcutaneous Injection Sites for Cachexia Patients: Technique and Site Rotation

Safe Subcutaneous Administration in Wasting Syndromes

Patients with cachexia (severe weight/muscle loss) have reduced subcutaneous tissue, making site selection and technique critical for absorption, comfort, and tissue preservation.

Recommended Sites & Technique

Site	Landmark	Needle Angle	Key Technique
Abdomen	2 inches from umbilicus, avoid belt line, scars, stoma	90° (if pinch ≥1 inch) or 45°	Pinch generous fold; inject slowly; rotate quadrants
Upper Outer Thigh	Mid-anterolateral, 2–4 inches below hip	45–90° (based on pinch)	Pinch vastus lateralis; avoid femoral triangle
Upper Arm (Triceps)	Posterior mid-arm, 2 inches below acromion	45° (usually)	Pinch triceps; patient relaxes arm; may need assistance
Upper Outer Buttock	Ventrogluteal: palm on greater trochanter, index to ASIS, inject in V	90°	Preferred for volume >1 mL; minimal nerves/vessels; patient prone/side-lying

Critical Considerations for Cachexia

• Assess Pinch: If <1 inch subcutaneous tissue, use 45° angle or shorter needle (4–5 mm).
• Rotate Religiously: Use a clock-face or quadrant system. Document site/date.
• Needle Gauge: 25–31G (insulin/syringe) for comfort; 23–25G for viscous meds.
• Volume Limit: ≤1 mL per site (≤2 mL in ventrogluteal if tissue allows).
• Skin Prep: Alcohol swab, dry 30 sec. No massage post-injection (except heparin).
• Monitor: Lipohypertrophy, atrophy, nodules, bruising. Avoid damaged sites.

Medications Commonly Given Subcut in Cachexia

• Erythropoiesis-stimulating agents (ESAs)
• Granulocyte colony-stimulating factor (G-CSF)
• Insulin, GLP-1 agonists
• Octreotide, somatostatin analogs
• Hydration (hypodermoclysis)